Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors.
Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors. Med Oncol. 2003; 20(1):7-12.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Filgrastim
Granulocyte Colony-Stimulating Factor
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms
Neutropenia
Paclitaxel
Recombinant Proteins
Salvage Therapy
Taxoids
Treatment Outcome
authors with profiles
Bruce E. Brockstein
Mark J. Ratain